The lived experiences of adults with T2-low severe asthma

  • Research type

    Research Study

  • Full title

    Exploring the lived experiences of adults with T2-low severe asthma.

  • IRAS ID

    269992

  • Contact name

    David McCormack

  • Contact email

    d.mccormack@qub.ac.uk

  • Sponsor organisation

    Queen's University Belfast

  • Clinicaltrials.gov Identifier

    N/A, N/A

  • Duration of Study in the UK

    1 years, 0 months, 23 days

  • Research summary

    The proposed study will investigate the lived experiences of adults with T-2 low severe asthma. People with T2-low severe asthma have difficult-to-treat symptoms, including breathlessness, wheeze and cough. In spite of treatment, patients continue to experience persistent symptoms, as well as unnecessary exposure to side effects.
    How T-2 low severe asthma impacts adults diagnosed with this condition is yet to be understood. Results from the proposed investigation will facilitate such understanding and will lend itself to further research, which will be important to ongoing development of assessment and treatment pathways through evidence-based practice.

    The study employs a qualitative methodological design. Participants are adults aged 18 years and over, known to a respiratory service in the Belfast Health and Social Care Trust, with a diagnosis of T-2 low severe asthma, and with the ability to speak sufficient English to partake in an interview. Physicians at the clinic will inform patients that fulfil inclusion criteria of the study during an appointment. Individuals who opt in and consent to participate in the study will complete a semi-structured interview for up to 60 minutes. Interviews will be transcribed verbatim and an interpretative phenomenological analysis of this data will be conducted.

  • REC name

    Wales REC 7

  • REC reference

    20/WA/0087

  • Date of REC Opinion

    7 May 2020

  • REC opinion

    Further Information Favourable Opinion